1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cheek Augmentation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cheek Augmentation Market, by Procedure Type
8.1.1 Dermal Filler-based Cheek Augmentation
8.1.1.1. Market Revenue and Forecast
8.1.2. Fat Grafting (Autologous Fat Transfer)
8.1.2.1. Market Revenue and Forecast
8.1.3. Cheek Implants (Surgical)
8.1.3.1. Market Revenue and Forecast
9.1. Cheek Augmentation Market, by Product Type
9.1.1. Hyaluronic Acid (HA) Fillers
9.1.1.1. Market Revenue and Forecast
9.1.2. Calcium Hydroxylapatite (CaHA) Fillers
9.1.2.1. Market Revenue and Forecast
9.1.3. Poly-L-lactic Acid (PLLA) Fillers
9.1.3.1. Market Revenue and Forecast
9.1.4. Other Fillers (PMMA, collagen)
9.1.4.1. Market Revenue and Forecast
10.1. Cheek Augmentation Market, by End-User
10.1.1. Specialty Aesthetic & Cosmetic Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Hospitals & Multispecialty Clinics
10.1.2.1. Market Revenue and Forecast
10.1.3. Medical Spas & Dermatology Centers
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Procedure Type
11.1.2. Market Revenue and Forecast, by Product Type
11.1.3. Market Revenue and Forecast, by End-User
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Procedure Type
11.1.4.2. Market Revenue and Forecast, by Product Type
11.1.4.3. Market Revenue and Forecast, by End-User
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Procedure Type
11.1.5.2. Market Revenue and Forecast, by Product Type
11.1.5.3. Market Revenue and Forecast, by End-User
11.2. Europe
11.2.1. Market Revenue and Forecast, by Procedure Type
11.2.2. Market Revenue and Forecast, by Product Type
11.2.3. Market Revenue and Forecast, by End-User
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Procedure Type
11.2.4.2. Market Revenue and Forecast, by Product Type
11.2.4.3. Market Revenue and Forecast, by End-User
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Procedure Type
11.2.5.2. Market Revenue and Forecast, by Product Type
11.2.5.3. Market Revenue and Forecast, by End-User
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Procedure Type
11.2.6.2. Market Revenue and Forecast, by Product Type
11.2.6.3. Market Revenue and Forecast, by End-User
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Procedure Type
11.2.7.2. Market Revenue and Forecast, by Product Type
11.2.7.3. Market Revenue and Forecast, by End-User
11.3. APAC
11.3.1. Market Revenue and Forecast, by Procedure Type
11.3.2. Market Revenue and Forecast, by Product Type
11.3.3. Market Revenue and Forecast, by End-User
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Procedure Type
11.3.4.2. Market Revenue and Forecast, by Product Type
11.3.4.3. Market Revenue and Forecast, by End-User
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Procedure Type
11.3.5.2. Market Revenue and Forecast, by Product Type
11.3.5.3. Market Revenue and Forecast, by End-User
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Procedure Type
11.3.6.2. Market Revenue and Forecast, by Product Type
11.3.6.3. Market Revenue and Forecast, by End-User
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Procedure Type
11.3.7.2. Market Revenue and Forecast, by Product Type
11.3.7.3. Market Revenue and Forecast, by End-User
11.4. MEA
11.4.1. Market Revenue and Forecast, by Procedure Type
11.4.2. Market Revenue and Forecast, by Product Type
11.4.3. Market Revenue and Forecast, by End-User
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Procedure Type
11.4.4.2. Market Revenue and Forecast, by Product Type
11.4.4.3. Market Revenue and Forecast, by End-User
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Procedure Type
11.4.5.2. Market Revenue and Forecast, by Product Type
11.4.5.3. Market Revenue and Forecast, by End-User
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Procedure Type
11.4.6.2. Market Revenue and Forecast, by Product Type
11.4.6.3. Market Revenue and Forecast, by End-User
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Procedure Type
11.4.7.2. Market Revenue and Forecast, by Product Type
11.4.7.3. Market Revenue and Forecast, by End-User
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Procedure Type
11.5.2. Market Revenue and Forecast, by Product Type
11.5.3. Market Revenue and Forecast, by End-User
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Procedure Type
11.5.4.2. Market Revenue and Forecast, by Product Type
11.5.4.3. Market Revenue and Forecast, by End-User
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Procedure Type
11.5.5.2. Market Revenue and Forecast, by Product Type
11.5.5.3. Market Revenue and Forecast, by End-User
12.1. AbbVie Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Merz Pharma GmbH & Co. KGaA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Galderma SA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Sientra, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Stryker Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Sinclair
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Johnson & Johnson Services, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Anika Therapeutics, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Hanson Medical Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Zimmer Biomet
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
